Biocept, Inc. (BIOCQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 19, 2024, 4:00 PM EST

Biocept Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2017 - 2013
Period Ending
Jun '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2017 - 2013
Net Income
-30.61-32.09-2.82-17.81-25.14-24.57
Upgrade
Depreciation & Amortization
1.831.661.531.090.930.8
Upgrade
Loss (Gain) From Sale of Assets
0.050.010-0--
Upgrade
Stock-Based Compensation
1.413.232.460.940.870.62
Upgrade
Other Operating Activities
-1.410.621.112.261.69-0.01
Upgrade
Change in Accounts Receivable
11.7811.640.36-10.62-1.95-0.38
Upgrade
Change in Inventory
1.71.89-0.72-1.41-0.19-0.05
Upgrade
Change in Accounts Payable
-2.7-5.86-0.414.470.010.6
Upgrade
Change in Other Net Operating Assets
0.365.622.191.290.730.63
Upgrade
Operating Cash Flow
-17.6-13.293.69-19.79-23.05-22.36
Upgrade
Capital Expenditures
-0.68-0.81-1.57-0.87-0.74-0.15
Upgrade
Sale of Property, Plant & Equipment
0.08-----
Upgrade
Investing Cash Flow
-0.61-0.81-1.57-0.87-0.74-0.15
Upgrade
Long-Term Debt Repaid
--2.11-1.77-1.54-0.93-1.92
Upgrade
Net Debt Issued (Repaid)
-2.19-2.11-1.77-1.54-0.93-1.92
Upgrade
Issuance of Common Stock
4.10.2414.1527.2630.625.69
Upgrade
Financing Cash Flow
1.91-1.8712.3825.7229.6623.78
Upgrade
Net Cash Flow
-16.3-15.9714.55.075.881.28
Upgrade
Free Cash Flow
-18.28-14.12.12-20.65-23.78-22.5
Upgrade
Free Cash Flow Margin
-1346.87%-54.51%3.46%-75.21%-430.21%-692.26%
Upgrade
Free Cash Flow Per Share
-26.47-24.944.30-52.31-345.36-
Upgrade
Cash Interest Paid
0.20.320.290.240.250.61
Upgrade
Cash Income Tax Paid
-----0
Upgrade
Levered Free Cash Flow
-4.24-9.220.86-14.75-15.48-13.61
Upgrade
Unlevered Free Cash Flow
-4.11-9.021.05-14.6-15.32-13.42
Upgrade
Change in Net Working Capital
-14.05-6.89-0.136.11.98-0.47
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.